[Induction of cytoplasmatic and genic respiration defective mutants by the carcinogen nitrosamide l-nitroso-imidazolidone-2 in Saccharomyces cerevisiae].
D002273:Carcinogens / Q000494:pharmacology*; D003593:Cytoplasm / Q000187:drug effects*; D005796:Genes / Q000187:drug effects; D005816:Genetic Complementation Test; D005827:Genetics, Microbial / Q000187:drug effects*; D006238:Haploidy / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology*; D009153:Mutagens / Q000494:pharmacology*; D009154:Mutation / Q000187:drug effects*; D009603:Nitroso Compounds / Q000494:pharmacology*; D012440:Saccharomyces / Q000187:drug effects*
D002273:Carcinogens; D007093:Imidazoles; D009153:Mutagens; D009603:Nitroso Compounds
Induktion von cytoplasmatischen und genischen Atmungsdefekt-Mutanten durch das carcinogene Nitrosamid l-Nitroso-imidazolidon-2 an Saccharomyces cerevisiae.